SCHEMBL7284929

SCHEMBL7284929

CCC([O])NCCc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 6/20 0.55
ATM Q13315 1/20 0.50
TAAR1 Q96RJ0 1/20 0.50
POLB P06746 1/20 0.49
OPRK1 P41145 1/20 0.46
TSHR P16473 2/20 0.45
NPC1 O15118 1/20 0.45
KDM1A O60341 1/20 0.45
ALDH1A1 P00352 1/20 0.45
LMNA P02545 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
HTR1A P08908 1/20 0.45
ADRA2A P08913 1/20 0.45
CYP2C8 P10632 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
IDO1 P14902 1/20 0.45
NFKB1 P19838 1/20 0.45
MAOA P21397 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19334491 0.80 SIGMAR1 (0.58) SIGMAR1ATMTAAR1POLBOPRK1
SCHEMBL9768698 0.80 SIGMAR1 (0.58) SIGMAR1ATMTAAR1POLBOPRK1
SCHEMBL18435350 0.78 SIGMAR1 (0.72) SIGMAR1ATMTAAR1OPRK1SMN1; SMN2
SCHEMBL10939197 0.77 SIGMAR1 (0.55) SIGMAR1ATMTAAR1POLBOPRK1
SCHEMBL27849653 0.77 POLB (0.53) SIGMAR1ATMTAAR1POLBOPRK1
SCHEMBL9150896 0.76 SIGMAR1 (0.62) SIGMAR1ATMTAAR1MEN1KMT2A
SCHEMBL1148376 0.75 SIGMAR1 (0.68) SIGMAR1ATMTAAR1OPRK1TSHR
SCHEMBL10767308 0.73 SIGMAR1 (0.59) SIGMAR1ATMTAAR1OPRK1TSHR
SCHEMBL11023396 0.73 SIGMAR1 (0.70) SIGMAR1ATMTAAR1OPRK1
SCHEMBL5079892 0.73 POLB (0.49) SIGMAR1POLBOPRK1TSHRNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5508403-A ENHANCES EFFECTS OF ANTITUMOR AGENTS NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1996-04-16 US disclosed
EP-0353692-B1 Drug effect-enhancing agent for antitumor drug NISSAN CHEMICAL IND LTD (JP) 1995-10-04 EP disclosed
EP-0655455-A1 Novel phosporus containing pyridine derivatives NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1995-05-31 EP disclosed
US-5304550-A Synergistic NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1994-04-19 US disclosed
US-5130303-A Pyridine derivative administering NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1992-07-14 US disclosed
EP-0353692-A2 Drug effect-enhancing agent for antitumor drug NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1990-02-07 EP disclosed